ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma

Second Affiliated Hospital, Zhejiang University, School of Medicine · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
na
relapse multiple myeloma, car-t therapy, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 804436
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.